Protagonist Therapeutics, Inc

SILVERCREST ASSET MANAGEMENT GROUP LLC PTGX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

53,217

Value ($000)

4,648

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	4,648	0.0%	53,217	12/31/2025
2025 Q3	11/14/2025	3,535	0.0%	53,217	9/30/2025
2025 Q2	8/14/2025	3,025	0.0%	54,723	6/30/2025
2025 Q1	5/15/2025	2,646	0.0%	54,723	3/31/2025
2024 Q4	2/14/2025	3,259	0.0%	84,426	12/31/2024
2024 Q3	11/14/2024	3,836	0.0%	85,254	9/30/2024
2024 Q2	8/15/2024	6,624	0.0%	191,168	6/30/2024
2024 Q1	5/15/2024	5,460	0.0%	188,743	3/31/2024
2023 Q4	2/14/2024	4,139	0.0%	180,496	12/31/2023
2023 Q3	11/14/2023	3,010	0.0%	180,462	9/30/2023
2023 Q2	8/14/2023	3,541	0.0%	128,197	6/30/2023
2023 Q1	5/15/2023	2,607	0.0%	113,355	3/31/2023
2022 Q4	2/14/2023	2,627	0.0%	240,745	12/31/2022
2022 Q3	11/14/2022	2,049	0.0%	243,013	9/30/2022
2022 Q2	8/15/2022	908	0.0%	114,759	6/30/2022
2022 Q1	5/16/2022	2,838	0.0%	119,834	3/31/2022
2021 Q4	2/14/2022	4,060	0.0%	118,715	12/31/2021
2021 Q3	11/15/2021	1,264	0.0%	71,343	9/30/2021
2021 Q2	8/16/2021	5,358	0.0%	119,391	6/30/2021